Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.95B |
| 2 |
NVIDIA
NVDA
|
+$1.63B |
| 3 |
Visa
V
|
+$1.09B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.05B |
| 5 |
Amazon
AMZN
|
+$917M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.48B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.36B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.06B |
| 4 |
iShares MSCI India ETF
INDA
|
+$827M |
| 5 |
iShares MBS ETF
MBB
|
+$767M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.58% |
| 2 | Consumer Discretionary | 2.07% |
| 3 | Financials | 1.9% |
| 4 | Healthcare | 1.47% |
| 5 | Industrials | 1.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8576
PUT
Liquidia Corp
LQDA
$8.02B
| $125K | ﹤0.01% |
+10,400
| New | +$138K |
|
8577
PUT
Upwork
UPWK
$1.19B
| $125K | ﹤0.01% |
11,600
-8,500
| -42% | -$96.4K |
|
8578
InnovAge Holding
INNV
$1.52B
| $124K | ﹤0.01% |
24,986
+9,149
| +58% | +$39.7K |
|
8579
Pioneer Bancorp
PBFS
$434M
| $124K | ﹤0.01% |
+12,366
| New | +$118K |
|
|
BORR
8580
PUT
Borr Drilling
BORR
$1.19B
| $123K | ﹤0.01% |
19,200
+4,200
| +28% | +$25.3K |
|
8581
Haleon
HLN
$44.2B
| $122K | ﹤0.01% |
14,808
-736,706
| -98% | -$6.16M |
|
8582
Cue Biopharma
CUE
$114M
| $122K | ﹤0.01% |
+3,287
| New | +$163K |
|
|
DHC
8583
PUT
Diversified Healthcare Trust
DHC
$2.14B
| $122K | ﹤0.01% |
40,000
| – | – |
|
|
TERN
8584
CALL
DELISTED
Terns Pharmaceuticals
TERN
| $122K | ﹤0.01% |
+17,900
| New | +$108K |
|
|
DOMA
8585
DELISTED
Doma Holdings, Inc.
DOMA
| $122K | ﹤0.01% |
+20,063
| New | +$121K |
|
8586
Mammoth Energy Services
TUSK
$163M
| $122K | ﹤0.01% |
37,098
+16,433
| +80% | +$56.4K |
|
|
CMAX
8587
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $121K | ﹤0.01% |
+43,548
| New | +$136K |
|
8588
YieldMax AI Option Income Strategy ETF
AIYY
$27.1M
| $121K | ﹤0.01% |
1,030
-2,886
| -74% | -$358K |
|
8589
PUT
Annexon
ANNX
$886M
| $121K | ﹤0.01% |
+24,700
| New | +$128K |
|
8590
Fennec Pharmaceuticals
FENC
$402M
| $121K | ﹤0.01% |
19,804
+4,250
| +27% | +$35.3K |
|
8591
Eve Holding
EVEX
$962M
| $121K | ﹤0.01% |
29,861
+19,750
| +195% | +$99.5K |
|
|
SRTA
8592
Strata Critical Medical Inc
SRTA
$512M
| $121K | ﹤0.01% |
34,741
-152,672
| -81% | -$509K |
|
|
RDNW
8593
RideNow Group
RDNW
$262M
| $119K | ﹤0.01% |
29,037
-166,866
| -85% | -$914K |
|
8594
PUT
WisdomTree
WT
$3.22B
| $119K | ﹤0.01% |
+12,000
| New | +$113K |
|
8595
CALL
Emergent Biosolutions
EBS
$248M
| $119K | ﹤0.01% |
+17,400
| New | +$74.9K |
|
8596
PUT
Fastly Inc
FSLY
$3.66B
| $119K | ﹤0.01% |
16,100
-43,100
| -73% | -$422K |
|
8597
D-Wave Quantum Inc. Common Stock
QBTS
$7.73B
| $117K | ﹤0.01% |
103,032
-90,471
| -47% | -$127K |
|
8598
ProKidney
PROK
$337M
| $117K | ﹤0.01% |
47,475
-44,201
| -48% | -$119K |
|
|
MOND
8599
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $117K | ﹤0.01% |
48,595
+38,080
| +362% | +$84.9K |
|
8600
Pyxis Oncology
PYXS
$236M
| $117K | ﹤0.01% |
35,209
-140,043
| -80% | -$589K |
|
Similar funds
Jane Street's Q2 2024 Portfolio in Review
As of Q2 2024, Jane Street held 10,566 positions worth $438B, down 8.5% from $478B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Jane Street withdrew a net $64.5B in Q2 2024, closing 1,331 positions and reducing 3,257 holdings. Its most notable exit was iShares MSCI EAFE Small-Cap ETF, an estimated $254M position sold in full.
By sector, the portfolio is most concentrated in Technology at 4.6% of assets, up from 2.4% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jane Street opened a new position in iShares Bitcoin Trust worth $221M.
- Jane Street's largest Q2 2024 buy was iShares Bitcoin Trust: 6,474,742 shares worth $221M.
- Jane Street added most to Apple in Q2 2024, an estimated $2.95B increase.
- Jane Street's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.48B.
- Jane Street fully exited iShares MSCI EAFE Small-Cap ETF in Q2 2024, selling an estimated $254M.
- Jane Street's ten largest holdings make up 43% of its $438B portfolio in Q2 2024.
- Jane Street opened 1,468 new positions and closed 1,331 in Q2 2024.
- Jane Street's portfolio value fell 8.5% quarter-over-quarter to $438B.
Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.